Response: Commentary: Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances

Bibliographic Details
Main Authors: Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Saleh M. Abdullah, Natália Cruz-Martins, Gaber El-Saber Batiha
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.738798/full
_version_ 1818738535179485184
author Hayder M. Al-kuraishy
Ali I. Al-Gareeb
Saleh M. Abdullah
Natália Cruz-Martins
Natália Cruz-Martins
Natália Cruz-Martins
Gaber El-Saber Batiha
author_facet Hayder M. Al-kuraishy
Ali I. Al-Gareeb
Saleh M. Abdullah
Natália Cruz-Martins
Natália Cruz-Martins
Natália Cruz-Martins
Gaber El-Saber Batiha
author_sort Hayder M. Al-kuraishy
collection DOAJ
first_indexed 2024-12-18T01:10:29Z
format Article
id doaj.art-a7a922e598e1400489aa92d75b810f12
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-12-18T01:10:29Z
publishDate 2021-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-a7a922e598e1400489aa92d75b810f122022-12-21T21:26:08ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2021-10-01810.3389/fcvm.2021.738798738798Response: Commentary: Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic DisturbancesHayder M. Al-kuraishy0Ali I. Al-Gareeb1Saleh M. Abdullah2Natália Cruz-Martins3Natália Cruz-Martins4Natália Cruz-Martins5Gaber El-Saber Batiha6Department of Clinical Pharmacology and Medicine, College of Medicine, Al-Mustansiriya University, Baghdad, IraqDepartment of Clinical Pharmacology and Medicine, College of Medicine, Al-Mustansiriya University, Baghdad, IraqDepartment of Medical Laboratory Technology, Faculty of Applied Medical Sciences, Jazan University, Jazan, Saudi ArabiaFaculty of Medicine, University of Porto, Porto, PortugalInstitute for Research and Innovation in Health (i3S), University of Porto, Porto, PortugalInstitute of Research and Advanced Training in Health Sciences and Technologies (CESPU), Gandra, PortugalDepartment of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour, Egypthttps://www.frontiersin.org/articles/10.3389/fcvm.2021.738798/fullGilbert syndrome (GS)SARS-CoV-2 (2019-nCoV)hyperbilirubinemiaCOVID - 19Crigler–Najjar syndrome type II
spellingShingle Hayder M. Al-kuraishy
Ali I. Al-Gareeb
Saleh M. Abdullah
Natália Cruz-Martins
Natália Cruz-Martins
Natália Cruz-Martins
Gaber El-Saber Batiha
Response: Commentary: Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances
Frontiers in Cardiovascular Medicine
Gilbert syndrome (GS)
SARS-CoV-2 (2019-nCoV)
hyperbilirubinemia
COVID - 19
Crigler–Najjar syndrome type II
title Response: Commentary: Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances
title_full Response: Commentary: Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances
title_fullStr Response: Commentary: Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances
title_full_unstemmed Response: Commentary: Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances
title_short Response: Commentary: Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances
title_sort response commentary case report hyperbilirubinemia in gilbert syndrome attenuates covid 19 induced metabolic disturbances
topic Gilbert syndrome (GS)
SARS-CoV-2 (2019-nCoV)
hyperbilirubinemia
COVID - 19
Crigler–Najjar syndrome type II
url https://www.frontiersin.org/articles/10.3389/fcvm.2021.738798/full
work_keys_str_mv AT haydermalkuraishy responsecommentarycasereporthyperbilirubinemiaingilbertsyndromeattenuatescovid19inducedmetabolicdisturbances
AT aliialgareeb responsecommentarycasereporthyperbilirubinemiaingilbertsyndromeattenuatescovid19inducedmetabolicdisturbances
AT salehmabdullah responsecommentarycasereporthyperbilirubinemiaingilbertsyndromeattenuatescovid19inducedmetabolicdisturbances
AT nataliacruzmartins responsecommentarycasereporthyperbilirubinemiaingilbertsyndromeattenuatescovid19inducedmetabolicdisturbances
AT nataliacruzmartins responsecommentarycasereporthyperbilirubinemiaingilbertsyndromeattenuatescovid19inducedmetabolicdisturbances
AT nataliacruzmartins responsecommentarycasereporthyperbilirubinemiaingilbertsyndromeattenuatescovid19inducedmetabolicdisturbances
AT gaberelsaberbatiha responsecommentarycasereporthyperbilirubinemiaingilbertsyndromeattenuatescovid19inducedmetabolicdisturbances